Repurposing and optimization of drugs for discovery of novel antifungals

MJ Donlin, MJ Meyers - Drug discovery today, 2022 - Elsevier
Highlights•There is a dire need for novel antifungal therapies.•Recent clinical trials of directly
repurposed drugs have failed.•The most recently approved antifungals underwent …

Repurposing and optimization of drugs for discovery of novel antifungals

MJ Donlin, MJ Meyers - Drug discovery today, 2022 - pubmed.ncbi.nlm.nih.gov
Although fungal diseases are a major and growing public health concern, there are only four
major classes of drug to treat primary fungal pathogens. The pipeline of new antifungals in …

Repurposing and optimization of drugs for discovery of novel antifungals.

MJ Donlin, MJ Meyers - Drug Discovery Today, 2022 - europepmc.org
Although fungal diseases are a major and growing public health concern, there are only four
major classes of drug to treat primary fungal pathogens. The pipeline of new antifungals in …

[HTML][HTML] Repurposing and optimization of drugs for discovery of novel anti-fungals

MJ Donlin, MJ Meyers - Drug discovery today, 2022 - ncbi.nlm.nih.gov
Fungal diseases are a major and growing public health concern, but despite that, there are
only four major classes of drugs to treat primary fungal pathogens. The pipeline of new …

Repurposing and optimization of drugs for discovery of novel antifungals

MJ Donlin, MJ Meyers - Drug Discovery Today, 2022 - Elsevier
Highlights•There is a dire need for novel antifungal therapies.•Recent clinical trials of directly
repurposed drugs have failed.•The most recently approved antifungals underwent …